| 摘要 |
Disclosed herein are tablets for sublingual administration comprising microparticles of buprenorphine or a pharmaceutically-acceptable salt thereof, particles of a weak acid, naloxone or a pharmaceutically-acceptable salt thereof and a disintegrant. The tablets are intended to provide a mode of abuse-resistant treatment for opioid dependence. |
